Edward H. Eiland
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Use and Resistance 9
-
- Antimicrobial Resistance in Staphylococcus 6
- Clostridium difficile and Clostridium perfringens research 2
- Co-authors
- Thomas M. English (3 shared papers)Lea S. Eiland (2 shared papers)Raymond A. Lorenz (1 shared paper)Kurt A. Wargo (3 shared papers)Jerod Nagel (1 shared paper)James G. Stevenson (1 shared paper)Keith S. Kaye (1 shared paper)Daryl D. DePestel (2 shared papers)
- Journals
- Clinical Infectious Diseases (3 papers)American Journal of Health-System Pharmacy (2 papers)Annals of Pharmacotherapy (2 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)American Journal of Kidney Diseases (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Edward H. Eiland
17 papers receiving 361 citations
Peers
Comparison fields: 5 of 73
- Applied Microbiology and Biotechnology 77
- Clinical Biochemistry 74
- Pharmacology 131
- Infectious Diseases 137
- Nephrology 44
Countries citing papers authored by Edward H. Eiland
This map shows the geographic impact of Edward H. Eiland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward H. Eiland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward H. Eiland more than expected).
Fields of papers citing papers by Edward H. Eiland
This network shows the impact of papers produced by Edward H. Eiland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward H. Eiland. The network helps show where Edward H. Eiland may publish in the future.
Co-authors
The 20 scholars most cited alongside Edward H. Eiland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 87 | |
| 2 | 2013 | 66 | |
| 3 | 2006 | 59 | |
| 4 | 2014 | 38 | |
| 5 | 2014 | 37 | |
| 6 | Zanamivir for the prevention of influenza in adults and children age 5 years and older. | 2007 | 19 |
| 7 | 2014 | 14 | |
| 8 | 2014 | 11 | |
| 9 | 2017 | 10 | |
| 10 | 2010 | 9 | |
| 11 | Analysis of adherence to national nosocomial pneumonia treatment guidelines. | 2007 | 8 |
| 12 | 2008 | 4 | |
| 13 | 2005 | 3 | |
| 14 | 2014 | 2 | |
| 15 | 2010 | 2 | |
| 16 | 2011 | 2 | |
| 17 | 2008 | 2 | |
| 18 | 2007 | 1 | |
| 19 | 2008 | 0 | |
| 20 | 2008 | 0 |
About Edward H. Eiland
Edward H. Eiland is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Clinical Biochemistry, Pharmacology and Epidemiology, having authored 20 papers that have together received 374 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (4 papers), Patient Satisfaction in Healthcare (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (77 citations), Clinical Biochemistry (74 citations), Pharmacology (131 citations), Infectious Diseases (137 citations) and Nephrology (44 citations). Edward H. Eiland has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Thomas M. English, Lea S. Eiland, Raymond A. Lorenz, Kurt A. Wargo, Jerod Nagel, James G. Stevenson, Keith S. Kaye, Daryl D. DePestel, Christopher J. Destache and Katherine Lusardi. Their work appears in journals such as Clinical Infectious Diseases, American Journal of Health-System Pharmacy, Annals of Pharmacotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and American Journal of Kidney Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.